Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol.
Southren A L, l'Hommedieu D, Gordon G G, Weinstein B I
AI Summary
Topical 3 alpha, 5 beta-tetrahydrocortisol lowered elevated eye pressure in rabbits, suggesting this natural steroid antagonist could treat primary open-angle glaucoma.
Abstract
3 alpha, 5 beta-tetrahydrocortisol, previously considered an inactive metabolite of cortisol, was found to lower significantly the intraocular pressure (IOP) of rabbits made ocular hypertensive with dexamethasone alone or with threshold levels of dexamethasone plus 5 beta-dihydrocortisol. The ocular hypotensive effect appeared within 3-7 days after the metabolite was started and persisted through the duration of the experiments. The metabolite did not lower the IOP of ocular normotensive untreated animals. Thus, 3 alpha,5 beta-tetrahydrocortisol is a naturally occurring steroid antagonist, which may be of use in the treatment of primary open-angle glaucoma.
MeSH Terms
Shields Classification
Related Articles5
Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard.
Basic ScienceTopically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
Basic ScienceThe organophosphate pesticide chlorpyrifos affects form deprivation myopia.
Basic ScienceRetinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation.
Basic ScienceAdenosine A2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats.
Basic ScienceIs this article assigned to the wrong chapter(s)? Let us know.